M

Mural Oncology PLC
NASDAQ:MURA

Watchlist Manager
Mural Oncology PLC
NASDAQ:MURA
Watchlist
Price: 2.04 USD Market Closed
Market Cap: 35.4m USD

Net Margin
Mural Oncology PLC

0%
Current
0%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-119.1m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Mural Oncology PLC
Glance View

Market Cap
35.3m USD
Industry
Biotechnology

Mural Oncology PLC is a IE-based company operating in Biotechnology industry. Mural Oncology plc is a clinical-stage oncology company. The firm is leveraging its protein engineering platform to develop cytokine-based immunotherapies for the treatment of cancer. The company leverages its expertise in cytokine biology, immune cell modulation and protein engineering capabilities to develop immunotherapies. The firm is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers, particularly those with limited treatment options available. Its portfolio of programs includes Nemvaleukin alfa (Nemvaleukin)-IL-2, IL-12, and IL-18. Nemvaleukin is an engineered interleukin-2 (IL-2) variant designed to harness the potent anti-cancer capabilities of high-dose rhIL-2 while minimizing toxicity by selectively activating cancer-fighting CD8 T cells and NK cells. The tumor-targeted split IL-12 program focuses on delivering the therapeutic potential of IL-12 by splitting it into inactive component.

MURA Intrinsic Value
8.33 USD
Undervaluation 76%
Intrinsic Value
Price
M
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-119.1m
/
Revenue
0
What is the Net Margin of Mural Oncology PLC?

Based on Mural Oncology PLC's most recent financial statements, the company has Net Margin of 0%.

Back to Top